WebApr 6, 2024 · Curis NasdaqGM:CRIS Stock Report Last Price US$0.54 Market Cap US$52.5m 7D 0.6% 1Y -78.1% Updated 25 Mar, 2024 Data Company Financials + 4 Analysts CRIS Stock Overview About the company Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of … WebMar 30, 2024 · benzinga.com - August 18 at 9:55 AM. Investors in Curis (NASDAQ:CRIS) from five years ago are still down 87%, even after 15% gain this past week. finance.yahoo.com - August 13 at 11:18 AM. Form 3 CURIS INC For: Aug 05 Filed by: Duvall Diantha - StreetInsider.com.
Curis, Inc. (CRIS) Stock Forum & Discussion - Yahoo Finance
WebMar 31, 2024 · LEXINGTON, Mass., April 5, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on March 31, 2024, the independent Compensation Committee of the Board of Directors of Curis approved the grant of … WebFounded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a... bioprosthesis heart valve icd 10
Curis (Nasdaq:CRIS) - Stock Price, News & Analysis - Simply Wall St
WebJun 11, 2024 · Friday morning, Curis published updated data from a phase 1/2 clinical trial of its CA-4948, a drug targeting acute myeloid leukemia and myelodysplastic syndromes. … WebSep 8, 2024 · Curis ( CRIS -7.41%), a small-cap cancer specialist, posted a healthy gain in August. The biotech's shares rose by 16.6% last month, according to data provided by S&P Global Market Intelligence.... WebJun 11, 2024 · Jun. 11, 2024, 09:56 AM. Curis Inc (NASDAQ:CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid leukemia (AML) or high-risk myelodysplastic ... dairycostings.com